PhRMA attacks New Mexico’s ‘short on detail’ plan for Canadian drug imports
Industry group PhRMA continues to fight a Trump-era final rule to allow drug imports from Canada as the lobbying group has now petitioned the FDA …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
